US pharmacy pricing
Novolin R Prices at US Pharmacies
Lowest price found · US pharmacies
$46.71/fill
for Novolin R, across the pharmacies in our data
US pharmacy prices — 10ml of 100unit/ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $46.71Lowest | $49.71 | $6.40 | |
| $46.71Lowest | $49.71 | $6.40 | |
| $48.86 | $51.86 | $6.40 | |
| $50.70 | $53.70 | $6.40 | |
| $57.16 | $57.16 | $6.40 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Novolin R.
Frequently asked questions
How much does Novolin R (Novolin R) cost without insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Novolin R is around $46.71. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Novolin R available?
Generic and brand-name pricing for Novolin R is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
What can I expect to pay for Novolin R with health insurance?
The copay for Novolin R varies significantly depending on your specific health insurance plan's formulary and coverage tier. It's advisable to contact your insurer or pharmacy benefits manager for exact cost details. In some cases, using a pharmacy savings card may offer a lower price than your insurance copay, so comparing both prices at the pharmacy counter can help ensure you get the best available rate.
Is a generic form of Novolin R available?
No, a generic version of Novolin R (human insulin) is not currently on the market. It remains under brand-name patent protection, manufactured by Novo Nordisk.
What is Novolin R and how is it used?
Novolin R is a short-acting, man-made (recombinant) human insulin used to control high blood sugar in people with type 1 or type 2 diabetes. It mimics the function of natural insulin, helping glucose enter cells for energy. Its activity profile is characterized by an onset of action within about 30 minutes of injection, a peak effect in 2 to 3 hours, and a duration of up to 8 hours. It is often used in combination with a longer-acting insulin or other diabetes medications. Effective management of diabetes with Novolin R, alongside diet and exercise, helps reduce the risk of serious long-term complications such as nerve damage, kidney disease, vision problems, and cardiovascular events.